Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002443574 | SCV002732189 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-08-17 | criteria provided, single submitter | clinical testing | The c.2253_2283del31 pathogenic mutation, located in coding exon 14 of the MSH2 gene, results from a deletion of 31 nucleotides at nucleotide positions 2253 to 2283, causing a translational frameshift with a predicted alternate stop codon (p.R752*). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |